261 related articles for article (PubMed ID: 22936676)
41. PI3Kγ ablation does not promote diabetes in
Breasson L; Sardi C; Becattini B; Zani F; Solinas G
FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
[TBL] [Abstract][Full Text] [Related]
42. Antioxidant N-acetylcysteine protects pancreatic β-cells against aldosterone-induced oxidative stress and apoptosis in female db/db mice and insulin-producing MIN6 cells.
Jin HM; Zhou DC; Gu HF; Qiao QY; Fu SK; Liu XL; Pan Y
Endocrinology; 2013 Nov; 154(11):4068-77. PubMed ID: 24008345
[TBL] [Abstract][Full Text] [Related]
43. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
Maki T; Gottschalk R; Monaco AP
Transplantation; 2002 Dec; 74(12):1684-6. PubMed ID: 12499880
[TBL] [Abstract][Full Text] [Related]
44. [Effect of early intervention with rhein on islet function in db/db mice].
DU H; Shao JQ; Gu P; Wang J; Liu ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1526-9. PubMed ID: 21945758
[TBL] [Abstract][Full Text] [Related]
45. Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice.
Kanda Y; Hashiramoto M; Shimoda M; Hamamoto S; Tawaramoto K; Kimura T; Hirukawa H; Nakashima K; Kaku K
J Nutr Biochem; 2015 Mar; 26(3):219-26. PubMed ID: 25488546
[TBL] [Abstract][Full Text] [Related]
46. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Brinkmann V; Nadler JL; Lynch KR
Clin Immunol; 2003 Apr; 107(1):30-5. PubMed ID: 12738247
[TBL] [Abstract][Full Text] [Related]
47. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Penaranda C; Tang Q; Ruddle NH; Bluestone JA
Diabetes; 2010 Jun; 59(6):1461-8. PubMed ID: 20299465
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.
Chu KY; Lau T; Carlsson PO; Leung PS
Diabetes; 2006 Feb; 55(2):367-74. PubMed ID: 16443769
[TBL] [Abstract][Full Text] [Related]
49. Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote.
Kanda Y; Shimoda M; Tawaramoto K; Hamamoto S; Tatsumi F; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
Endocr J; 2009; 56(8):997-1008. PubMed ID: 19706988
[TBL] [Abstract][Full Text] [Related]
50. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
[TBL] [Abstract][Full Text] [Related]
52. The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice.
Dalbøge LS; Almholt DL; Neerup TS; Vrang N; Jelsing J; Fosgerau K
J Pharmacol Exp Ther; 2014 Aug; 350(2):353-60. PubMed ID: 24902584
[TBL] [Abstract][Full Text] [Related]
53. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice.
Uchiyama K; Naito Y; Hasegawa G; Nakamura N; Takahashi J; Yoshikawa T
Redox Rep; 2002; 7(5):290-3. PubMed ID: 12688512
[TBL] [Abstract][Full Text] [Related]
54. Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice.
Du H; Shao J; Gu P; Lu B; Ye X; Liu Z
J Endocrinol Invest; 2012 Jun; 35(6):607-12. PubMed ID: 22776972
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of p38 mitogen-activated protein kinase exerts a hypoglycemic effect by improving β cell function via inhibition of β cell apoptosis in db/db mice.
Wei X; Gu N; Feng N; Guo X; Ma X
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1494-1500. PubMed ID: 30284474
[TBL] [Abstract][Full Text] [Related]
56. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
[TBL] [Abstract][Full Text] [Related]
57. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.
Jörns A; Rath KJ; Terbish T; Arndt T; Meyer Zu Vilsendorf A; Wedekind D; Hedrich HJ; Lenzen S
Endocrinology; 2010 Aug; 151(8):3555-65. PubMed ID: 20501676
[TBL] [Abstract][Full Text] [Related]
58. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
[TBL] [Abstract][Full Text] [Related]
59. The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function.
Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
Diabetes Obes Metab; 2011 Jan; 13(1):34-41. PubMed ID: 21114601
[TBL] [Abstract][Full Text] [Related]
60. Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice.
Heilmann A; Schinke T; Bindl R; Wehner T; Rapp A; Haffner-Luntzer M; Liedert A; Amling M; Ignatius A
J Orthop Res; 2013 Nov; 31(11):1845-50. PubMed ID: 23818033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
